1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Roesch, P. Seidel, G. Schaefer, W. Esswein, A. Hofmann, E. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C6 H13 N O2 131.173 n NORLEUCINE L-peptide linking C5 H12 N2 O2 132.161 n L-ornithine L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking NE Febs Lett. FEBLAL 0165 0014-5793 444 239 244 10.1016/S0014-5793(98)01658-5 10050767 The structure of human parathyroid hormone-related protein(1-34) in near-physiological solution. 1999 10.2210/pdb1hth/pdb pdb_00001hth 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 4116.704 CYCLIC PARATHYROID HORMONE RESIDUES 1-34 M8NLE, K13ORN, S17E, M18NLE 1 man polymer no yes SVSEIQL(NLE)HNLG(ORN)HLNE(NLE)ERVEWLRKKLQDVHNF SVSEIQLLHNLGAHLNELERVEWLRKKLQDVHNF A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HUMAN sample Homo sapiens database_2 pdbx_database_status struct_conn struct_ref_seq_dif repository Initial release Version format compliance Non-polymer description Version format compliance Database references Derived calculations Other 1 0 1997-10-15 1 1 2008-03-24 1 2 2011-07-13 1 3 2021-11-03 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_conn.pdbx_leaving_atom_flag _struct_conn.ptnr1_auth_comp_id _struct_conn.ptnr1_auth_seq_id _struct_conn.ptnr1_label_atom_id _struct_conn.ptnr1_label_comp_id _struct_conn.ptnr1_label_seq_id _struct_conn.ptnr2_auth_comp_id _struct_conn.ptnr2_auth_seq_id _struct_conn.ptnr2_label_atom_id _struct_conn.ptnr2_label_comp_id _struct_conn.ptnr2_label_seq_id _struct_ref_seq_dif.details Y BNL 1997-04-09 REL REL ENERGY, AGREEMENT WITH EXPERIMENTAL DATA 50 10 5.0 298 K SIMULATED ANNEALING, RESTRAINED MOLECULAR DYNAMICS BRUNGER refinement X-PLOR 3.1 structure solution NDEE structure solution X-PLOR 600 Bruker AMX600 SER 1 n 1 SER 1 A VAL 2 n 2 VAL 2 A SER 3 n 3 SER 3 A GLU 4 n 4 GLU 4 A ILE 5 n 5 ILE 5 A GLN 6 n 6 GLN 6 A LEU 7 n 7 LEU 7 A NLE 8 n 8 NLE 8 A HIS 9 n 9 HIS 9 A ASN 10 n 10 ASN 10 A LEU 11 n 11 LEU 11 A GLY 12 n 12 GLY 12 A ORN 13 n 13 ORN 13 A HIS 14 n 14 HIS 14 A LEU 15 n 15 LEU 15 A ASN 16 n 16 ASN 16 A GLU 17 n 17 GLU 17 A NLE 18 n 18 NLE 18 A GLU 19 n 19 GLU 19 A ARG 20 n 20 ARG 20 A VAL 21 n 21 VAL 21 A GLU 22 n 22 GLU 22 A TRP 23 n 23 TRP 23 A LEU 24 n 24 LEU 24 A ARG 25 n 25 ARG 25 A LYS 26 n 26 LYS 26 A LYS 27 n 27 LYS 27 A LEU 28 n 28 LEU 28 A GLN 29 n 29 GLN 29 A ASP 30 n 30 ASP 30 A VAL 31 n 31 VAL 31 A HIS 32 n 32 HIS 32 A ASN 33 n 33 ASN 33 A PHE 34 n 34 PHE 34 A author_defined_assembly 1 monomeric A NLE 8 NORLEUCINE A NLE 8 LEU A ORN 13 ORNITHINE A ORN 13 ALA A NLE 18 NORLEUCINE A NLE 18 LEU 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 20 0.136 SIDE CHAIN 1 A ARG 25 0.311 SIDE CHAIN 2 A ARG 20 0.259 SIDE CHAIN 2 A ARG 25 0.282 SIDE CHAIN 3 A ARG 20 0.276 SIDE CHAIN 3 A ARG 25 0.302 SIDE CHAIN 4 A ARG 20 0.276 SIDE CHAIN 4 A ARG 25 0.301 SIDE CHAIN 5 A ARG 20 0.236 SIDE CHAIN 5 A ARG 25 0.300 SIDE CHAIN 6 A ARG 20 0.186 SIDE CHAIN 6 A ARG 25 0.309 SIDE CHAIN 7 A ARG 20 0.185 SIDE CHAIN 7 A ARG 25 0.317 SIDE CHAIN 8 A ARG 20 0.229 SIDE CHAIN 8 A ARG 25 0.260 SIDE CHAIN 9 A ARG 20 0.254 SIDE CHAIN 9 A ARG 25 0.266 SIDE CHAIN 10 A ARG 20 0.216 SIDE CHAIN 10 A ARG 25 0.274 SIDE CHAIN 1 A ILE 5 -89.16 32.51 1 A ORN 13 -129.15 -53.62 1 A HIS 14 168.84 128.17 1 A NLE 18 -145.47 25.06 1 A GLU 19 -83.72 -77.26 1 A VAL 31 37.18 96.35 1 A HIS 32 -53.76 87.23 2 A ILE 5 -91.16 37.90 2 A LEU 11 -85.00 -87.85 2 A ORN 13 61.18 121.98 2 A HIS 14 -127.95 -122.75 2 A GLU 22 -70.84 -70.37 2 A LYS 26 -76.96 -165.16 2 A LYS 27 61.36 -88.81 2 A GLN 29 -46.01 101.87 2 A ASP 30 178.99 -38.94 2 A VAL 31 40.93 26.68 2 A HIS 32 39.05 50.44 2 A ASN 33 -92.56 30.61 3 A ORN 13 32.49 40.90 3 A HIS 14 74.44 127.09 3 A NLE 18 -96.63 30.89 3 A LYS 26 -80.11 37.11 3 A ASP 30 -100.71 53.14 4 A SER 3 -86.52 40.31 4 A GLN 6 -158.48 -50.70 4 A ORN 13 77.68 -4.40 4 A HIS 14 72.40 134.77 4 A LEU 28 80.01 -7.61 4 A HIS 32 -161.41 55.35 4 A ASN 33 166.19 -76.72 5 A VAL 2 53.04 -177.95 5 A ILE 5 -93.43 32.27 5 A HIS 14 -74.21 -97.29 5 A LYS 26 -98.46 37.08 5 A VAL 31 172.47 87.51 5 A HIS 32 -166.55 38.44 5 A ASN 33 -102.26 -77.82 6 A VAL 2 -63.40 -169.89 6 A ILE 5 -91.00 37.78 6 A ORN 13 -127.91 -51.81 6 A LYS 26 -83.66 44.94 6 A LYS 27 -143.07 -47.46 6 A VAL 31 -91.14 59.13 6 A HIS 32 178.56 -37.04 6 A ASN 33 70.18 94.91 7 A VAL 2 44.08 -171.97 7 A ILE 5 -91.30 41.71 7 A ORN 13 84.69 -33.23 7 A HIS 14 78.74 145.43 7 A LEU 24 -32.57 -35.73 7 A GLN 29 -88.18 39.73 7 A HIS 32 67.92 67.47 8 A SER 3 -56.74 100.04 8 A ORN 13 43.26 29.44 8 A HIS 14 73.60 137.46 8 A LEU 15 -85.20 31.31 8 A LEU 24 -33.39 -32.24 8 A GLN 29 -159.84 30.23 8 A VAL 31 70.52 108.02 8 A HIS 32 -134.08 -79.20 9 A GLU 4 -94.37 -77.93 9 A ASN 10 -84.49 -70.38 9 A HIS 14 -75.99 -131.85 9 A LYS 26 -78.45 36.61 9 A LEU 28 -143.53 15.39 9 A VAL 31 40.75 29.71 10 A ILE 5 -75.72 -163.98 10 A GLN 6 80.03 -71.40 10 A LEU 11 176.82 50.01 10 A ORN 13 -165.86 -112.96 10 A HIS 14 176.38 142.74 10 A GLU 22 -65.97 -71.18 10 A LEU 24 -39.76 -30.04 10 A VAL 31 70.43 129.34 10 A ASN 33 36.28 87.96 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 The solution structure of cyclic human parathyroid hormone fragment 1-34, NMR, 10 structures 1 Y N A GLU 4 A GLU 4 HELX_P A GLN 6 A GLN 6 5 1 3 A ARG 20 A ARG 20 HELX_P A GLN 29 A GLN 29 1 2 10 covale 1.291 both A LEU 7 A C LEU 7 1_555 A NLE 8 A N NLE 8 1_555 covale 1.307 both A NLE 8 A C NLE 8 1_555 A HIS 9 A N HIS 9 1_555 covale 1.305 both A GLY 12 A C GLY 12 1_555 A ORN 13 A N ORN 13 1_555 covale 1.306 both A ORN 13 A C ORN 13 1_555 A HIS 14 A N HIS 14 1_555 covale 1.306 one A ORN 13 A NE ORN 13 1_555 A GLU 17 A CD GLU 17 1_555 covale 1.304 both A GLU 17 A C GLU 17 1_555 A NLE 18 A N NLE 18 1_555 covale 1.303 both A NLE 18 A C NLE 18 1_555 A GLU 19 A N GLU 19 1_555 HORMONE HUMAN PARATHYROID HORMONE, CYCLIC, ORNITHINE, NORLEUCINE, HORMONE PTHY_HUMAN UNP 1 1 P01270 MIPAKDMAKVMIVMLAICFLTKSDGKSVKKRSVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQ RPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ 32 65 1HTH 1 34 P01270 A 1 1 34 1 MET engineered mutation NLE 8 1HTH A P01270 UNP 39 8 1 LYS engineered mutation ORN 13 1HTH A P01270 UNP 44 13 1 SER engineered mutation GLU 17 1HTH A P01270 UNP 48 17 1 MET engineered mutation NLE 18 1HTH A P01270 UNP 49 18 1 P 1